The Lamarckian genetic algorithm (AutoDock 3.0) was used to model the interaction/binding between m-iodo-p-methoxyHoechst (IMH), a ligand available in the Protein Data Bank whose binding to the minor groove of DNA has been demonstrated (crystal structure), and the oligonucleotide d CGCGAATTCGCG 2.
Our study demonstrates crystal deposition within a significant percentage of coronary arteries with one artery containing characteristic acicular, intracellular negatively birefringent crystals.
Tracer crystal experiments, using Zn-doped Al(OH 3 crystals, as well as the observed evolution of the experimental size distribution with time both demonstrate that crystals (or crystal aggregates) were agglomerating at sizes larger than the expected maximum aggregate size.
On a 1-l crystalliser, it was demonstrated that crystals of different shape can be obtained using the developed closed-loop control methodology.
All patients demonstrated corneal crystals or haze, or a combination of both findings.
The response of aptamer upon target binding was demonstrated by quartz crystal microbalance (QCM) method and the microstructure of hydrogel was characterized by SEM.
Cellulose-binding ability of Xyl10A CBM1 was demonstrated using quartz crystal microbalance with dissipation monitoring.
Here, we provide a link between ATP- and crystal-mediated inflammasome activation, demonstrating that crystals act through ATP release to induce IL-1 β maturation.
In cryogenic systems, for example, the recently demonstrated single-crystal silicon cavity (spacer and substrates, φSi = 1 × 10−8 at 124 K), the coating Brownian noise becomes the sole limiting factor in the laser frequency stability10.
The importance of zinc binding functional groups in ACE inhibition has been demonstrated in crystal structure and structure-activity studies [22, 30, 31].
Cho et al. demonstrated photonic crystal slab waveguides by the combination of holography and photolithography; defect lines were introduced extrinsically into a pre-patterned PhC structure [15].
